Fundamental Clinical Pharmacology

Accéder au contenu principal

Publié dans FCP.

FCP- Targeting Neuroinflammation in Alzheimer's Disease: Repurposed Nucleoside Reverse Transcriptase Inhibitors and the Therapeutic Potential of Kamuvudine-9

Now available:

Targeting Neuroinflammation in Alzheimer's Disease: Repurposed Nucleoside Reverse Transcriptase Inhibitors and the Therapeutic Potential of Kamuvudine-9

Dernière mise à jour le 27 mars 2026.

Publié dans FCP.

FCP- Factors Associated With Cocaine Use Disorder: Results From the French Nationwide Repeated Cross-Sectional OPPIDUM Study (2019–2023)

Now available in Open Access:

Factors Associated With Cocaine Use Disorder: Results From the French Nationwide Repeated Cross-Sectional OPPIDUM Study (2019–2023)

Dernière mise à jour le 27 mars 2026.

Publié dans FCP.

FCP- Non-Pulmonary Mechanisms of Action of Ambroxol in In Vivo Experimental Models: a Systematic Review

Now available in Open Access:

Non-Pulmonary Mechanisms of Action of Ambroxol in In Vivo Experimental Models: a Systematic Review

This article is part of the Drug repositioning special issue: Fundamental & Clinical Pharmacology Call for Papers Drug repositioning

More information about the FCP special issues:Fundamental & Clinical Pharmacology Call for Papers

Dernière mise à jour le 16 mars 2026.

Publié dans FCP.

FCP- Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024

Now available:

Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024

Dernière mise à jour le 26 février 2026.

Publié dans FCP.

FCP- Immunomodulatory Effects of Hyoscine Butylbromide on Mammalian Macrophages

Now available:

Immunomodulatory Effects of Hyoscine Butylbromide on Mammalian Macrophages

Dernière mise à jour le 23 février 2026.